When a Cook County jury returned a $51 million verdict in April 2026 against OSF Heart of Mary Medical Center, it sent an unmistakable signal to emergency rooms, insurers, and malpractice attorneys nationwide: failing to screen for diabetes carries catastrophic legal and financial consequences. The Reinke v. OSF Heart of Mary case — in which ER physicians dismissed a 47-year-old man’s symptoms as a tension headache without ever testing his blood sugar, leading to cardiac arrest and permanent brain injury — has become the defining benchmark for diabetes misdiagnosis malpractice settlement amounts in 2026. This guide breaks down what that verdict means for your claim, what the data says about average payouts, and which calculator inputs most powerfully drive compensation.
The Reinke Verdict: Why a $51M Award Is Reshaping Diabetes Misdiagnosis Claims
John Reinke, 47, presented to the OSF Heart of Mary emergency room with symptoms that — in the context of his documented obesity and gout, both recognized diabetes risk factors — warranted immediate blood glucose testing. ER physicians instead diagnosed a tension headache and discharged him. Days later, Reinke suffered cardiac arrest. He survived, but with permanent hypoxic brain injury requiring around-the-clock care. The April 2026 jury award exceeded $51 million, making it one of the largest Cook County medical malpractice verdicts in recent history.
Plaintiff attorney Jason Williams captured the case’s broader significance after the verdict: “I hope that screening for diabetes becomes a mantra in emergency rooms across the country.” That statement reflects not just the human toll of this single case but the systemic failure that courts are now valuing at eight figures. For anyone researching diabetes misdiagnosis malpractice settlement amounts, Reinke establishes the ceiling for cases involving cardiac arrest and permanent brain injury — and it is a very high ceiling.
Illinois is a particularly consequential jurisdiction for this analysis. Following the Illinois Supreme Court’s 2010 ruling in Lebron v. Gottlieb Memorial Hospital, Illinois has no cap on non-economic damages in medical malpractice cases as of 2026. That absence of a damages ceiling allowed the Reinke jury to award the full measure of John Reinke’s pain, suffering, and loss of life’s enjoyment without statutory limitation — a factor any plaintiff’s attorney evaluating a similar claim must weigh carefully.
National Data: What NPDB Statistics Reveal About Diabetes Malpractice Payouts
The Reinke verdict is dramatic, but it exists within a broader data landscape that reveals consistent, rising patterns in diabetes misdiagnosis malpractice settlement amounts. According to the National Practitioner Data Bank (NPDB), malpractice payments in 2026 continue a multi-year trend of increasing severity. The 2025 NPDB dataset recorded 11,502 malpractice payments totaling $5.27 billion nationwide, with an average paid claim of approximately $458,000 and a median of roughly $245,000.
Critically for diabetes claims, diagnostic errors account for approximately 33% of all medical malpractice payouts — the single largest category of any malpractice type. Failure-to-diagnose claims specifically pay between $145,000 and $695,000 on average per NPDB data, with the range expanding dramatically when catastrophic injury like brain damage or organ failure is involved. Understanding where your specific claim falls within that spectrum is precisely what a diabetes misdiagnosis malpractice settlement amounts calculator is designed to determine.
| Case / Data Point | Jurisdiction | Year | Amount | Key Injury |
|---|---|---|---|---|
| Reinke v. OSF Heart of Mary (verdict) | Cook County, IL | 2026 | $51M+ | Cardiac arrest, permanent brain injury |
| Gestational diabetes/macrosomia verdict | Wisconsin | 2025 | $29M | Fetal distress, failure to escalate care |
| Incorrect insulin / no replacement ordered | Virginia | 2024 | $2.35M | DKA, respiratory failure, cognitive impairment |
| Undiagnosed Type 1 / DKA hospitalization (child) | Not disclosed | 2024 | $875,000 | Diabetic ketoacidosis |
| Hyperglycemia delay / DKA wrongful death | Massachusetts | 2025 | $1M | DKA, wrongful death |
| Failure to prescribe insulin / kidney failure | Pennsylvania | Undated | $1.2M | Kidney failure requiring transplant, neuropathy |
| NPDB average paid claim (all malpractice) | Nationwide | 2025 | $458,000 | All categories |
| NPDB failure-to-diagnose range | Nationwide | 2025 | $145K–$695K | Diagnostic error |
These figures, drawn from NPDB reporting and verified case records, illustrate a clear injury-severity gradient. The gap between a $875,000 pediatric DKA settlement and a $51 million cardiac arrest verdict is not arbitrary — it reflects specific, calculable differences in economic damages, permanency of injury, and the presence or absence of brain damage. Use our brain injury calculator if your diabetes misdiagnosis claim involves hypoxic or anoxic brain injury, as those cases require a separate valuation methodology from standard failure-to-diagnose claims.
Types of Diabetes Misdiagnosis Claims and How Courts Value Them
Type 1 Diabetes: Failure to Diagnose in Acute Presentation
Type 1 diabetes misdiagnosis claims most commonly arise when a patient — frequently a child or young adult — presents with classic DKA symptoms (polyuria, polydipsia, abdominal pain, altered consciousness) and is sent home without blood glucose testing. The 2024 settlement of $875,000 for an undiagnosed pediatric Type 1 case with DKA hospitalization represents a relatively contained outcome because the child recovered without permanent organ damage. When DKA progresses to cerebral edema and brain injury, valuations climb sharply. The CDC’s diabetes surveillance data confirms that Type 1 DKA carries a measurable mortality and severe morbidity risk when diagnosis is delayed, which courts treat as a foreseeable consequence of diagnostic negligence.
Type 2 Diabetes: Failure to Screen High-Risk Patients
The Reinke case is the paradigm Type 2 failure-to-screen claim. When a patient presents with documented obesity, hypertension, gout, or metabolic syndrome — all recognized risk factors — and no clinician orders a simple blood glucose or HbA1c test, the standard of care has arguably been breached. Diabetes misdiagnosis malpractice settlement amounts in Type 2 failure-to-screen cases are driven primarily by what happens next: if the patient suffers DKA, cardiac arrest, stroke, or end-stage renal disease attributable to the undetected hyperglycemia, economic damages alone can exceed the $51 million Reinke benchmark once lifetime care costs are calculated.
Gestational Diabetes: The $29M Wisconsin Benchmark
Gestational diabetes mismanagement claims involve a distinct set of defendants — often certified nurse-midwives, OB-GYNs, and perinatologists — and a distinct set of injuries: macrosomia, shoulder dystocia, hypoxic-ischemic encephalopathy, and stillbirth. The 2025 Wisconsin verdict of $29 million arose from a certified nurse-midwife’s failure to escalate care despite clear signs of gestational diabetes, macrosomia, and fetal distress. When a child survives with permanent neurological impairment, life-care plans routinely project $10–$25 million in future care costs alone, which explains why gestational diabetes diabetes misdiagnosis malpractice settlement amounts can rival or exceed those for adult claims. For fatal gestational diabetes outcomes, consider using our wrongful death calculator to establish baseline economic loss before adding non-economic components.
Calculator Inputs That Drive Diabetes Misdiagnosis Settlement Values
Our diabetes misdiagnosis malpractice settlement calculator weighs six primary inputs to generate a defensible compensation range. Each is derived from documented case law and actuarial data, not estimates.
- Injury Severity Tier: Claims are stratified as DKA-only (lowest tier, $145K–$900K), cardiac arrest without permanent injury (mid-tier, $1M–$5M), and cardiac arrest with permanent brain injury or multi-organ failure (highest tier, $5M–$51M+). The Virginia $2.35M settlement (DKA, respiratory failure, cognitive impairment) and the Reinke $51M verdict anchor opposite ends of the spectrum above baseline.
- State Damage Cap Status: Illinois’s uncapped status directly enabled the Reinke verdict. States with hard non-economic caps — such as California’s current MICRA limits — can compress jury awards significantly. Cornell Law’s medical malpractice overview provides a starting framework for understanding how state-specific caps interact with jury verdicts.
- Economic Damages (Lost Wages + Lifetime Care): A 47-year-old with permanent brain injury requiring 24-hour skilled nursing care may project $15–$30 million in future care costs at 2026 rates, before adding lost earning capacity. This single input often determines whether a case settles in seven or eight figures.
- Pre-existing Diabetes vs. New Diagnosis: If a patient already carried a diabetes diagnosis and the claim involves mismanagement (wrong insulin, failure to monitor), the causation argument differs from a pure failure-to-diagnose claim. Pre-existing condition arguments by defense counsel can reduce recoverable damages by 20–40% depending on jurisdiction.
- Comparative Negligence: Patient delay in seeking care, non-compliance with prior medical advice, or failure to disclose symptoms are defense arguments that reduce plaintiff recovery in comparative fault states. A finding of 20% plaintiff fault reduces a $1M verdict to $800,000 in a pure comparative state.
- Policy Limits: Even the strongest claim is constrained by available insurance coverage. Hospital systems typically carry $5M–$25M in primary coverage with excess layers; individual physicians may carry $1M–$3M. Policy limits discovery is a critical early litigation step.
For claims involving defective insulin delivery devices or pharmacy software errors that contributed to the misdiagnosis or treatment failure, a mass tort settlement calculator may also be relevant if the device defect affected multiple patients.
DKA Injury Valuation: The Most Common Severe Outcome in Diabetes Claims
Diabetic ketoacidosis is the clinical bridge between a missed diagnosis and catastrophic injury in the majority of diabetes misdiagnosis malpractice settlement amounts claims. The Massachusetts 2025 wrongful death settlement of $1 million involved a delayed hyperglycemia treatment leading to DKA. The Virginia 2024 settlement of $2.35 million involved a physician-ordered insulin that was canceled by the pharmacy with no replacement, leaving the patient without insulin for nearly 48 hours — resulting in DKA, respiratory failure, and cognitive impairment.
What distinguishes a DKA claim that settles for $875,000 from one that settles for $2.35 million? The answer lies in residual injury. Full recovery from DKA with no lasting organ damage produces lower valuations. Persistent cognitive impairment, respiratory compromise requiring ongoing pulmonary care, or renal injury requiring dialysis or transplant — as in the Pennsylvania $1.2 million kidney failure case — adds quantifiable future medical costs that drive totals upward. Courts and juries apply the Bureau of Labor Statistics medical cost inflation indices to life-care plan projections, meaning future care costs in 2026 calculations are significantly higher than those projected in cases litigated five years ago.
When evaluating your own claim, understanding the intersection of DKA severity, residual injury classification, and state damage law is the essential first step toward estimating defensible diabetes misdiagnosis malpractice settlement amounts. Our calculator structures these inputs systematically so that you can generate a range before your first consultation with counsel. For general personal injury claims arising from the same incident, our personal injury settlement calculator provides a complementary baseline valuation.
Frequently Asked Questions About Diabetes Misdiagnosis Malpractice Settlements
What is the average settlement amount for a diabetes misdiagnosis malpractice claim?
Based on NPDB data, the average paid malpractice claim across all categories was approximately $458,000 in the most recent reporting period, with failure-to-diagnose claims ranging from $145,000 to $695,000 on average. However, diabetes misdiagnosis malpractice settlement amounts diverge sharply from these averages when catastrophic injury is involved. The Reinke v. OSF Heart of Mary verdict of $51 million in April 2026 and the Wisconsin gestational diabetes verdict of $29 million demonstrate that cases involving permanent brain injury, cardiac arrest, or severe fetal harm can reach eight figures. The correct answer for any individual claim depends on injury severity, state law, and economic damages — inputs our calculator is designed to quantify.
Can I sue for medical malpractice if my Type 2 diabetes was simply not caught early enough?
A delayed Type 2 diabetes diagnosis does not automatically constitute malpractice. The legal standard requires proving that the treating physician deviated from the accepted standard of care — meaning a reasonable physician in the same specialty, with access to the same patient information, would have ordered blood glucose screening. The Reinke case succeeded because John Reinke presented with documented obesity and gout (recognized risk factors) in an ER setting where basic metabolic panels are routine. If your physician had documented risk factors in your chart, failed to order recommended screening tests, and your delay in diagnosis caused measurable harm (DKA, organ damage, cardiac event), you likely have a viable claim. The strength of that claim — and the resulting diabetes misdiagnosis malpractice settlement amounts — depends on the severity of the harm caused by the delay.
How do state damage caps affect diabetes malpractice verdicts?
State damage caps on non-economic damages (pain and suffering, loss of consortium) can dramatically reduce jury verdicts. Illinois has no such cap as of 2026, which is why the Reinke verdict could reach $51 million without statutory reduction. States with active caps may limit non-economic recovery to as little as $250,000–$750,000 regardless of jury award, though economic damages (medical costs, lost wages) are typically uncapped even in capped states. When using our calculator, the state cap input is one of the most consequential variables for predicting diabetes misdiagnosis malpractice settlement amounts because it sets the legal ceiling on a major component of your recovery.
What evidence is needed to prove a diabetes misdiagnosis malpractice claim?
Successful diabetes misdiagnosis claims typically require four categories of evidence: (1) Medical records documenting the patient’s presentation, risk factors, and the clinician’s documented reasoning for not ordering glucose testing; (2) Expert testimony from an endocrinologist or emergency medicine physician establishing the standard of care and the specific deviation; (3) A causal link — often supported by treating physicians and life-care planners — between the missed diagnosis and the resulting injury (DKA, cardiac arrest, organ damage); and (4) Economic documentation including wage records, life-care plan projections, and expert opinions on future medical costs. In the Reinke case, the existence of documented obesity and gout in the ER chart, combined with the absence of any blood glucose order, made the standard-of-care deviation straightforward for the jury to evaluate.
How long do diabetes malpractice cases take to settle or reach verdict?
Diabetes misdiagnosis malpractice cases typically take 2–4 years from filing to resolution, though cases with clear liability and catastrophic injury may settle earlier. Cases that proceed to verdict, like Reinke v. OSF Heart of Mary, often involve disputed causation or damages that make early settlement difficult. The timeline is affected by: jurisdiction (some courts have 3–5 year trial dockets), complexity of medical evidence, number of defendants (hospital system, ER physician, pharmacist, etc.), and the plaintiff’s willingness to accept pre-trial offers. Diabetes misdiagnosis malpractice settlement amounts achieved through negotiated settlement are typically 60–85% of the projected jury verdict value, reflecting the risk and cost savings of avoiding trial for both parties.
This content is provided for general informational purposes only and does not constitute legal advice; consult a licensed attorney in your jurisdiction regarding the specific facts of your case.
Related reading: $25 Million Verdict: How Wrongful Death Damages Are Calculated When An Outpatient Surgery Center Lacks The Emergency Resources A Hospital Would Have Had
Christine Norwood is a medical malpractice research analyst with a background in healthcare quality and medical-legal analysis. She specializes in helping patients and families understand their rights when harmed by medical negligence. Ms. Norwood is not a physician or attorney and the information provided is for educational purposes only.